Moleculin Biotech (MBRX) PT Raised to $29 at Roth Capital, Adjusting PT After 1 To 6 Stock Split
Tweet Send to a Friend
Roth Capital analyst Jonathan Aschoff ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
